Westpac Banking Corp increased its position in shares of Stericycle Inc. (NASDAQ:SRCL) by 25.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,787 shares of the company’s stock after buying an additional 1,187 shares during the period. Westpac Banking Corp’s holdings in Stericycle were worth $603,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of SRCL. Balentine LLC increased its position in Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock worth $134,000 after buying an additional 275 shares in the last quarter. C M Bidwell & Associates Ltd. bought a new position in Stericycle during the first quarter worth approximately $300,000. USS Investment Management Ltd bought a new position in Stericycle during the first quarter worth approximately $80,866,000. NN Investment Partners Holdings N.V. bought a new position in Stericycle during the first quarter worth approximately $56,798,000. Finally, Columbia Partners L L C Investment Management increased its position in Stericycle by 0.3% in the first quarter. Columbia Partners L L C Investment Management now owns 60,318 shares of the company’s stock worth $7,611,000 after buying an additional 166 shares in the last quarter. 92.80% of the stock is owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) opened at 77.34 on Wednesday. Stericycle Inc. has a 1-year low of $76.76 and a 1-year high of $151.57. The stock has a market capitalization of $6.58 billion, a PE ratio of 27.22 and a beta of 0.20. The stock’s 50 day moving average price is $82.36 and its 200 day moving average price is $99.90.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. During the same period last year, the company posted $1.14 EPS. The business’s quarterly revenue was up 24.6% compared to the same quarter last year. Equities research analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current year.
A number of research analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Monday, July 25th. Imperial Capital downgraded shares of Stericycle from an “in-line” rating to an “underperform” rating and dropped their price objective for the company from $100.00 to $93.50 in a research note on Friday, July 29th. Jefferies Group reissued a “buy” rating and set a $125.00 target price (down previously from $140.00) on shares of Stericycle in a research report on Friday, July 29th. Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Finally, Macquarie assumed coverage on shares of Stericycle in a research report on Thursday, August 25th. They set a “neutral” rating and a $96.00 target price for the company. Three analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the stock. Stericycle has an average rating of “Hold” and an average price target of $103.54.
In other news, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The stock was sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now directly owns 1,088 shares in the company, valued at approximately $89,052.80. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Mark C. Miller sold 34,835 shares of Stericycle stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the sale, the director now owns 244,284 shares of the company’s stock, valued at $25,532,563.68. The disclosure for this sale can be found here. Company insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.